Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin

Cancer Cell. 2005 Mar;7(3):251-61. doi: 10.1016/j.ccr.2005.02.007.

Abstract

Angiogenesis inhibitors, such as TNP-470 and the nontoxic HPMA copolymer-TNP-470 (caplostatin), are emerging as a class of anticancer drugs. We report that TNP-470 and caplostatin inhibit vascular hyperpermeability of tumor blood vessels as well as that induced in mouse skin by different mediators. Treatment with TNP-470 or angiostatin for 3 days was sufficient to reduce permeability of tumor blood vessels, delayed-type hypersensitivity, and pulmonary edema induced by IL-2. TNP-470 also inhibited VPF/VEGF-induced phosphorylation of VEGFR-2, calcium influx, and RhoA activation in endothelial cells. These results identify an activity of TNP-470, that of inhibiting vessel hyperpermeability. This activity likely contributes to TNP-470's antiangiogenic effect and suggests that caplostatin can be used in the treatment of cancer and inflammation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiogenesis Inhibitors / chemistry*
  • Angiogenesis Inhibitors / pharmacology*
  • Angiostatins / pharmacology
  • Animals
  • Calcium / metabolism
  • Capillaries / drug effects*
  • Capillaries / metabolism
  • Capillaries / ultrastructure
  • Capillary Permeability / drug effects*
  • Capillary Permeability / physiology
  • Cell Movement / drug effects
  • Cyclohexanes
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Endothelial Cells / ultrastructure
  • Female
  • Hypersensitivity, Delayed
  • Interleukin-2 / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, SCID
  • Mitogen-Activated Protein Kinases / metabolism
  • Neoplasms / blood supply
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • O-(Chloroacetylcarbamoyl)fumagillol
  • Pulmonary Edema / chemically induced
  • Sesquiterpenes / chemistry*
  • Sesquiterpenes / pharmacology*
  • Skin / blood supply
  • Skin / drug effects
  • Skin / pathology
  • Vascular Endothelial Growth Factor A / metabolism
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism
  • rhoA GTP-Binding Protein / metabolism

Substances

  • Angiogenesis Inhibitors
  • Cyclohexanes
  • Interleukin-2
  • Sesquiterpenes
  • Vascular Endothelial Growth Factor A
  • Angiostatins
  • Vascular Endothelial Growth Factor Receptor-2
  • Mitogen-Activated Protein Kinases
  • rhoA GTP-Binding Protein
  • Calcium
  • O-(Chloroacetylcarbamoyl)fumagillol